Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Bain SC, Hansen BB, Malkin SJP, Nuhoho S, Valentine WJ, Chubb B, Hunt B, Capehorn M
Our team ensures that every injection is safe, effective, and tailored to your unique needs
The availability of an oral option represents a meaningful change for individuals seeking medically supported weight management without injectable delivery
In our real-world cohort, we observed no statistically significant between treatment differences for these key outcomes
Nausea Vomiting Diarrhea Constipation Decreased appetite Injection-site reactions Gallbladder events (cholelithiasis, cholecystitis) reported in some Phase 2 participants Increased heart rate Possible pancreatitis (per GLP-1 class data not specifically reported in retatrutide trials) Frequently asked questions Is retatrutide FDA-approved
